Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 129 Pages
Report ld: 6895541
Request Sample
Customized Report
Darunavir Ethanolate Market Size(US$)

CAGR 2026-2032
4.3%
Market Size,2032
USD 19.33
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Darunavir Ethanolate was estimated to be worth US$ 14.46 million in 2025 and is projected to reach US$ 19.33 million, growing at a CAGR of 4.3% from 2026 to 2032.
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Darunavir Ethanolate is an effective antiretroviral drug primarily used to treat patients with HIV/AIDS. The market demand for Darunavir Ethanolate has been continuously growing, driven by the expansion of the global HIV/AIDS treatment market and technological advancements. The market size has been expanding, covering various regions and countries. In the future, with the ongoing development in the healthcare industry and the increasing demand for HIV/AIDS treatment, the market for Darunavir Ethanolate is expected to continue its robust growth, providing patients with more efficient and convenient treatment options.
This report provides a comprehensive view of the global market for Darunavir Ethanolate, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Darunavir Ethanolate market size, estimations, and forecasts are presented in terms of sales volume (Ton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Darunavir Ethanolate.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Darunavir Ethanolate manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Darunavir Ethanolate sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Darunavir Ethanolate sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Darunavir Ethanolate Product Introduction
1.2 Global Darunavir Ethanolate Market Size Forecast
1.2.1 Global Darunavir Ethanolate Sales Value (2021–2032)
1.2.2 Global Darunavir Ethanolate Sales Volume (2021–2032)
1.2.3 Global Darunavir Ethanolate Sales Price (2021–2032)
1.3 Darunavir Ethanolate Market Trends & Drivers
1.3.1 Darunavir Ethanolate Industry Trends
1.3.2 Darunavir Ethanolate Market Drivers & Opportunities
1.3.3 Darunavir Ethanolate Market Challenges
1.3.4 Darunavir Ethanolate Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Darunavir Ethanolate Players Revenue Ranking (2025)
2.2 Global Darunavir Ethanolate Revenue by Company (2021–2026)
2.3 Global Darunavir Ethanolate Sales Volume Ranking of Players (2025)
2.4 Global Darunavir Ethanolate Sales Volume by Company (2021–2026)
2.5 Global Darunavir Ethanolate Average Price by Company (2021–2026)
2.6 Key Manufacturers Darunavir Ethanolate Manufacturing Base and Headquarters
2.7 Key Manufacturers Darunavir Ethanolate Product Offerings
2.8 Key Manufacturers Start of Mass Production of Darunavir Ethanolate
2.9 Darunavir Ethanolate Market Competitive Analysis
2.9.1 Darunavir Ethanolate Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Darunavir Ethanolate Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Darunavir Ethanolate revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Darunavir Ethanolate Market Classification
3.1 Introduction by Type
3.1.1 Purity 97%
3.1.2 Purity 98%
3.1.3 Purity 99%
3.1.4 Others
3.1.5 Global Darunavir Ethanolate Sales Value by Type
3.1.5.1 Global Darunavir Ethanolate Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Darunavir Ethanolate Sales Value, by Type (2021–2032)
3.1.5.3 Global Darunavir Ethanolate Sales Value, by Type (%), 2021–2032
3.1.6 Global Darunavir Ethanolate Sales Volume by Type
3.1.6.1 Global Darunavir Ethanolate Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Darunavir Ethanolate Sales Volume, by Type (2021–2032)
3.1.6.3 Global Darunavir Ethanolate Sales Volume, by Type (%), 2021–2032
3.1.7 Global Darunavir Ethanolate Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Darunavir Ethanolate Sales Value by Application
4.2.1 Global Darunavir Ethanolate Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Darunavir Ethanolate Sales Value, by Application (2021–2032)
4.2.3 Global Darunavir Ethanolate Sales Value, by Application (%), 2021–2032
4.3 Global Darunavir Ethanolate Sales Volume by Application
4.3.1 Global Darunavir Ethanolate Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Darunavir Ethanolate Sales Volume, by Application (2021–2032)
4.3.3 Global Darunavir Ethanolate Sales Volume, by Application (%), 2021–2032
4.4 Global Darunavir Ethanolate Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Darunavir Ethanolate Sales Value by Region
5.1.1 Global Darunavir Ethanolate Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Darunavir Ethanolate Sales Value by Region (2021–2026)
5.1.3 Global Darunavir Ethanolate Sales Value by Region (2027–2032)
5.1.4 Global Darunavir Ethanolate Sales Value by Region (%), 2021–2032
5.2 Global Darunavir Ethanolate Sales Volume by Region
5.2.1 Global Darunavir Ethanolate Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Darunavir Ethanolate Sales Volume by Region (2021–2026)
5.2.3 Global Darunavir Ethanolate Sales Volume by Region (2027–2032)
5.2.4 Global Darunavir Ethanolate Sales Volume by Region (%), 2021–2032
5.3 Global Darunavir Ethanolate Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Darunavir Ethanolate Sales Value, 2021–2032
5.4.2 North America Darunavir Ethanolate Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Darunavir Ethanolate Sales Value, 2021–2032
5.5.2 Europe Darunavir Ethanolate Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Darunavir Ethanolate Sales Value, 2021–2032
5.6.2 Asia Pacific Darunavir Ethanolate Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Darunavir Ethanolate Sales Value, 2021–2032
5.7.2 South America Darunavir Ethanolate Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Darunavir Ethanolate Sales Value, 2021–2032
5.8.2 Middle East & Africa Darunavir Ethanolate Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Darunavir Ethanolate Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Darunavir Ethanolate Sales Value and Sales Volume
6.2.1 Key Countries/Regions Darunavir Ethanolate Sales Value, 2021–2032
6.2.2 Key Countries/Regions Darunavir Ethanolate Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Darunavir Ethanolate Sales Value, 2021–2032
6.3.2 United States Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Darunavir Ethanolate Sales Value, 2021–2032
6.4.2 Europe Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Darunavir Ethanolate Sales Value, 2021–2032
6.5.2 China Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.5.3 China Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Darunavir Ethanolate Sales Value, 2021–2032
6.6.2 Japan Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Darunavir Ethanolate Sales Value, 2021–2032
6.7.2 South Korea Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Darunavir Ethanolate Sales Value, 2021–2032
6.8.2 Southeast Asia Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Darunavir Ethanolate Sales Value, 2021–2032
6.9.2 India Darunavir Ethanolate Sales Value by Type (%), 2025 vs 2032
6.9.3 India Darunavir Ethanolate Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 DC Chemicals
7.1.1 DC Chemicals Company Information
7.1.2 DC Chemicals Introduction and Business Overview
7.1.3 DC Chemicals Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 DC Chemicals Darunavir Ethanolate Product Offerings
7.1.5 DC Chemicals Recent Developments
7.2 Selleck Chemicals
7.2.1 Selleck Chemicals Company Information
7.2.2 Selleck Chemicals Introduction and Business Overview
7.2.3 Selleck Chemicals Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Selleck Chemicals Darunavir Ethanolate Product Offerings
7.2.5 Selleck Chemicals Recent Developments
7.3 AbMole BioScience
7.3.1 AbMole BioScience Company Information
7.3.2 AbMole BioScience Introduction and Business Overview
7.3.3 AbMole BioScience Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 AbMole BioScience Darunavir Ethanolate Product Offerings
7.3.5 AbMole BioScience Recent Developments
7.4 MedChemExpress (MCE)
7.4.1 MedChemExpress (MCE) Company Information
7.4.2 MedChemExpress (MCE) Introduction and Business Overview
7.4.3 MedChemExpress (MCE) Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 MedChemExpress (MCE) Darunavir Ethanolate Product Offerings
7.4.5 MedChemExpress (MCE) Recent Developments
7.5 APExBIO Technology
7.5.1 APExBIO Technology Company Information
7.5.2 APExBIO Technology Introduction and Business Overview
7.5.3 APExBIO Technology Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 APExBIO Technology Darunavir Ethanolate Product Offerings
7.5.5 APExBIO Technology Recent Developments
7.6 Key Organics
7.6.1 Key Organics Company Information
7.6.2 Key Organics Introduction and Business Overview
7.6.3 Key Organics Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Key Organics Darunavir Ethanolate Product Offerings
7.6.5 Key Organics Recent Developments
7.7 Combi-Blocks
7.7.1 Combi-Blocks Company Information
7.7.2 Combi-Blocks Introduction and Business Overview
7.7.3 Combi-Blocks Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Combi-Blocks Darunavir Ethanolate Product Offerings
7.7.5 Combi-Blocks Recent Developments
7.8 Hairui Chemical
7.8.1 Hairui Chemical Company Information
7.8.2 Hairui Chemical Introduction and Business Overview
7.8.3 Hairui Chemical Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Hairui Chemical Darunavir Ethanolate Product Offerings
7.8.5 Hairui Chemical Recent Developments
7.9 LGC
7.9.1 LGC Company Information
7.9.2 LGC Introduction and Business Overview
7.9.3 LGC Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 LGC Darunavir Ethanolate Product Offerings
7.9.5 LGC Recent Developments
7.10 AstaTech
7.10.1 AstaTech Company Information
7.10.2 AstaTech Introduction and Business Overview
7.10.3 AstaTech Darunavir Ethanolate Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 AstaTech Darunavir Ethanolate Product Offerings
7.10.5 AstaTech Recent Developments
8 Industry Chain Analysis
8.1 Darunavir Ethanolate Industrial Chain
8.2 Darunavir Ethanolate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Darunavir Ethanolate Sales Model
8.5.2 Sales Channels
8.5.3 Darunavir Ethanolate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Darunavir Ethanolate market was valued at US$ 14.46 million in 2025 and is anticipated to reach US$ 19.33 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 126
USD 2900.00
(Single User License)
The global Darunavir Ethanolate market is projected to grow from US$ 13.9 million in 2024 to US$ 18.6 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 140
USD 4900.00
(Single User License)
The global market for Darunavir Ethanolate was valued at US$ 13.9 million in the year 2024 and is projected to reach a revised size of US$ 18.6 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-02-15
Pages: 92
USD 2900.00
(Single User License)
The global Darunavir Ethanolate market size was US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 80
USD 4250.00
(Single User License)
The global market for Darunavir Ethanolate was estimated to be worth US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 100
USD 3950.00
(Single User License)
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published Date: 2024-02-26
Pages: 102
USD 2900.00
(Single User License)
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published Date: 2024-01-10
Pages: 130
USD 3950.00
(Single User License)
The global Darunavir Ethanolate market was valued at US$ 14.46 million in 2025 and is anticipated to reach US$ 19.33 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-04-21
Pages: 126
The global Darunavir Ethanolate market is projected to grow from US$ 13.9 million in 2024 to US$ 18.6 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 140
The global market for Darunavir Ethanolate was valued at US$ 13.9 million in the year 2024 and is projected to reach a revised size of US$ 18.6 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-02-15
Pages: 92
The global Darunavir Ethanolate market size was US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 80
The global market for Darunavir Ethanolate was estimated to be worth US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 100
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published: 2024-04-12
Pages: 105
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published: 2024-02-26
Pages: 102
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published: 2024-01-10
Pages: 130
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now